###begin article-title 0
###xml 130 134 <span type="species:ncbi:10090">Mice</span>
12/15-Lipoxygenase Is Required for the Early Onset of High Fat Diet-Induced Adipose Tissue Inflammation and Insulin Resistance in Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: DDS YM. Performed the experiments: DDS PDM JC JMO FA DT YM. Analyzed the data: DDS PDM JC DT YM. Contributed reagents/materials/analysis tools: DDS PDM JC YM. Wrote the paper: DDS PDM YM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Recent understanding that insulin resistance is an inflammatory condition necessitates searching for genes that regulate inflammation in insulin sensitive tissues. 12/15-lipoxygenase (12/15LO) regulates the expression of proinflammatory cytokines and chemokines and is implicated in the early development of diet-induced atherosclerosis. Thus, we tested the hypothesis that 12/15LO is involved in the onset of high fat diet (HFD)-induced insulin resistance.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 353 354 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 361 362 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1126 1130 <span type="species:ncbi:10090">mice</span>
Cells over-expressing 12/15LO secreted two potent chemokines, MCP-1 and osteopontin, implicated in the development of insulin resistance. We assessed adipose tissue inflammation and whole body insulin resistance in wild type (WT) and 12/15LO knockout (KO) mice after 2-4 weeks on HFD. In adipose tissue from WT mice, HFD resulted in recruitment of CD11b+, F4/80+ macrophages and elevated protein levels of the inflammatory markers IL-1beta, IL-6, IL-10, IL-12, IFNgamma, Cxcl1 and TNFalpha. Remarkably, adipose tissue from HFD-fed 12/15LO KO mice was not infiltrated by macrophages and did not display any increase in the inflammatory markers compared to adipose tissue from normal chow-fed mice. WT mice developed severe whole body (hepatic and skeletal muscle) insulin resistance after HFD, as measured by hyperinsulinemic euglycemic clamp. In contrast, 12/15LO KO mice exhibited no HFD-induced change in insulin-stimulated glucose disposal rate or hepatic glucose output during clamp studies. Insulin-stimulated Akt phosphorylation in muscle tissue from HFD-fed mice was significantly greater in 12/15LO KO mice than in WT mice.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
These results demonstrate that 12/15LO mediates early stages of adipose tissue inflammation and whole body insulin resistance induced by high fat feeding.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 480 483 480 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-deLuca1">[1]</xref>
###xml 485 488 485 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Matsuzawa1">[2]</xref>
###xml 625 628 625 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Hotamisligil1">[3]</xref>
###xml 787 790 784 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-deLuca1">[1]</xref>
###xml 926 929 923 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Park1">[4]</xref>
###xml 931 934 928 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Strissel1">[5]</xref>
###xml 1201 1204 1198 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Park1">[4]</xref>
###xml 1206 1209 1203 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Nguyen1">[6]</xref>
###xml 1210 1213 1207 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Kraegen1">[8]</xref>
###xml 1554 1557 1551 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Park1">[4]</xref>
###xml 1558 1561 1555 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Nguyen1">[6]</xref>
###xml 293 299 <span type="species:ncbi:9606">humans</span>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
Insulin resistance is a pathophysiological condition associated with obesity, aging, and type 2 diabetes that affects skeletal muscle, liver, adipose tissue, and immune cells. Obesity and insulin resistance are associated with macrophage infiltration and inflammation in the adipose tissue of humans and rodent models where a feed-forward cycle of reciprocal adipocyte and macrophage activation results in the secretion of inflammatory proteins and further macrophage recruitment [1], [2]. Pro-inflammatory factors secreted by macrophages and adipocytes are elevated in adipose tissue from obese and type 2 diabetic patients [3]. Adipose tissue inflammation induces insulin resistance through inactivation of insulin receptor substrates (IRS) by cytokine-activated JNK, IKKbeta and SOCS [1]. High fat diet (HFD) feeding, a commonly studied model of insulin resistance in rodents, rapidly causes progressive metabolic maladies [4], [5]. Insulin resistance in heart, adipose tissue, liver, and muscle, adipose tissue hypertrophy and inflammatory cell infiltration, and hyperinsulinemia are significantly robust phenotypes observed as early as 1-3 weeks of HFD, with minimal to no total body weight gain [4], [6]-[8]. After 16-20 weeks of HFD, these phenotypes are much more pronounced and additional severe metabolic dysregulations are present including dyslipidemia & ectopic triglyceride storage, hypo-adiponectinemia, adipose tissue hypoxia, cell death and remodeling, beta-cell decompensation, mild hyperglycemia, and deterioration of cardiac function [4]-[6]. The key molecules involved in initiating HFD-induced adipose tissue inflammation and macrophage infiltration are not well characterized. Recent studies suggest an important role for 12/15-lipoxygenase (12/15LO) in monocyte recruitment to and regulation of inflammation in vascular and adipose tissue.
###end p 9
###begin p 10
###xml 110 112 110 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 122 124 122 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 222 224 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 234 236 234 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 696 699 696 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Natarajan1">[9]</xref>
###xml 700 704 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Pidgeon1">[14]</xref>
###xml 1014 1018 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Browse1">[15]</xref>
###xml 1020 1024 1020 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Delker1">[16]</xref>
###xml 1153 1157 1149 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Bolick1">[12]</xref>
###xml 1159 1163 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Natarajan2">[17]</xref>
###xml 1278 1282 1274 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Miller1">[18]</xref>
###xml 1284 1288 1280 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Miller2">[19]</xref>
###xml 1454 1458 1446 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Dwarakanath1">[20]</xref>
###xml 1459 1463 1451 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Wen2">[26]</xref>
###xml 458 465 <span type="species:ncbi:3847">soybean</span>
###xml 472 477 <span type="species:ncbi:9606">human</span>
###xml 509 514 <span type="species:ncbi:10090">mouse</span>
The family of 12/15LO enzymes catalyzes the insertion of molecular oxygen in arachidonic acid (20:4) at the 12th and/or 15th carbon, resulting in a fatty acid hydroperoxide. 12/15LO oxygenates linoleic acid (18:2) at the 9th and/or 13th carbon. Free unsaturated fatty acids as well as fatty acids esterified in phospholipids and cholesteryl esters are substrates for 12/15LO. The 12/15LO enzymes are conserved among many plant and animal species and include soybean 15LO, human 15LO (Entrez Gene ID 246), and mouse 12/15LO (Entrez Gene ID 11687). In mammals, 12/15LO is expressed in differentiated macrophages, dendritic cells, inflamed endothelial and smooth muscle cells, and in certain tumors [9]-[14]. There is an emerging understanding that, in both plants and mammals, 12/15LO products are involved in the signaling processes of defense response and inflammation. In plants, 12/15LO initiates the synthesis of jasmonic acid, which regulates defensive genes that respond to wound- and insect-inflicted damage [15], [16]. In mammalian cells, 12/15LO products regulate small GTPases Ras and RhoA, MAP kinases, PKC, and transcription factor NF-kappaB [12], [17]. Our previous studies suggest that 12/15LO oxidation products activate toll-like receptor-4 (TLR4) in macrophages [18], [19]. Cells that express 12/15LO or are activated with 12/15LO oxidation products produce MCP-1, IL-6, IL-8 and TNFalpha and induce monocyte binding to endothelial cells [20]-[26].
###end p 10
###begin p 11
###xml 227 231 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Persaud1">[27]</xref>
###xml 294 298 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Chen1">[28]</xref>
###xml 445 449 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-McDuffie1">[29]</xref>
###xml 639 643 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Nunemaker1">[30]</xref>
###xml 1003 1006 997 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Natarajan1">[9]</xref>
###xml 1008 1012 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Dwarakanath2">[22]</xref>
###xml 1014 1018 1008 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Natarajan4">[31]</xref>
###xml 1020 1024 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Li2">[32]</xref>
###xml 1237 1241 1231 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Cyrus1">[33]</xref>
###xml 1242 1246 1236 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Bolick2">[36]</xref>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
12/15LO has been implicated in the development of autoimmune diabetes and in vascular complications of diabetes. Arachidonic acid stimulates insulin secretion by beta-cells and this process is inhibited by the 12/15LO activity [27]. Moreover, 12/15LO mediates cytokine-induced beta-cell damage [28]. Other data suggest that non-obese diabetic (NOD) mice congenic for a targeted deletion of 12/15LO are in fact protected from autoimmune diabetes [29]. A recent study has shown that long-term (8-24 weeks) high fat feeding induces 12/15LO activation and beta cell damage in pancreatic islets, both of which were prevented in 12/15LO KO mice [30]. 12/15LO is also involved in vascular complications of advanced diabetes, such as atherosclerosis and nephropathy, which manifest life-threatening conditions. Specifically under diabetic conditions, vascular smooth muscle cells (VSMC) express 12/15LO which in turn mediates a VSMC switch from a contractile phenotype to a migratory and inflammatory phenotype [9], [22], [31], [32]. This change together with 12/15LO-mediated lipoprotein oxidation and monocyte adhesion to endothelial cells explains the involvement of 12/15LO in the pathogenesis of high fat diet (HFD)-induced atherosclerosis [33]-[36].
###end p 11
###begin p 12
###xml 233 237 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Nunemaker1">[30]</xref>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
Although these previous studies show that 12/15LO plays a role in regulating beta-cell survival, advanced diabetic complications and, in a very recent publication, chronic (8-24 weeks) HFD-induced insulin resistance and inflammation [30], the possible involvement of 12/15LO in the early development of insulin resistance has not been studied. Given that 12/15LO is an inflammatory modulator, we asked whether it is required for the onset of HFD-induced insulin resistance. We found that 12/15LO deficiency protected mice from exhibiting elevated inflammatory markers in adipose tissue and, remarkably, prevented whole-body insulin resistance induced by 2-4 weeks of high fat feeding.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Cells
###end title 14
###begin p 15
###xml 92 96 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Benz1">[37]</xref>
###xml 98 102 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Ezaki1">[38]</xref>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
Murine fibroblast cell lines stably over-expressing human 15LO or beta-galactosidase (LacZ) [37], [38] were cultured in 10% FBS/DMEM/gentamicin with 0.5 mg/ml G418 (Calbiochem, San Diego, CA) to maintain selection.
###end p 15
###begin title 16
Animals
###end title 16
###begin p 17
###xml 1215 1259 1203 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Guide for Care and Use of Laboratory Animals</italic>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">Mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
###xml 875 880 <span type="species:ncbi:10090">mouse</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1039 1043 <span type="species:ncbi:10090">Mice</span>
Male C57BL6 wild type mice were from Jackson Laboratories. Male 12/15LO knockout mice, backcrossed in a C57BL6 background for 10 generations, were a generous gift from Dr. Colin Funk (Queen's University). Starting 16 weeks of age, mice were fed either normal chow (12% kcal from fat; Purina 5001 Lab Diet) of high fat diet (41% kcal from fat; TD96132, Harlan Teklad) for 2 or 4 weeks. All mice involved in clamp studies (wild type and 12/15LO KO, n = 20 each) were singly housed during the two weeks of dietary intervention. This was done in order to ensure equal food access, protect the implanted catheters, and prevent fighting between mice. Mice used for other experiments (acute insulin and adipose tissue FACS studies, n = 20 per strain) were housed 1-3 in a cage. There were infrequent circumstances (approximately5 mice total in these studies) when a non-clamp study mouse was singly-housed (for example, an aggressor had to be separated from cage mates to prevent stress and injury to the other mice and to ensure access to food. Mice were housed under controlled light (12:12 light:dark) and climate conditions with unlimited access to food and water. All procedures were performed in accordance with the Guide for Care and Use of Laboratory Animals of the National Institutes of Health and were approved by the University of California, San Diego, Animal Subjects Committee.
###end p 17
###begin title 18
Analytical methods
###end title 18
###begin p 19
Total RNA was isolated from cell lysates using an RNeasy kit from Quiagen (Valencia, CA). Quantitative RT-PCR was performed to measure MCP-1, OPN and GAPDH mRNA levels using a Rotor-Gene RG3000 qPCR machine (Corbett Research, Brisbane, Australia). Primers and probes were from Applied Biosystems (Foster City, CA). The protein levels of MCP-1 in conditioned media were measured by ELISA using a kit from R&D Systems (Minneapolis, MN). The protein levels of OPN in conditioned media were assayed by immunoblot using a primary antibody from Santa Cruz Biotechnology (Santa Cruz, CA).
###end p 19
###begin title 20
In vivo metabolic studies
###end title 20
###begin p 21
###xml 913 917 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Miles1">[39]</xref>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
Insulin sensitivity was assessed in mice fed HFD for 2 weeks using a sub-maximal hyperinsulinemic euglycemic glucose clamp technique as previously described (34), with the following modifications: 1) isoflurane was used for anesthesia during the catheter insertion surgery three days prior to clamp, 2) glucose tracer was infused at 2 muCi/hr during the clamp, and 3) insulin was infused at 3 mU/kg/min during the clamp. The mice were conscious during the clamp and fully recovered after the procedure. Four days later, the mice were fasted for 5 hr, anesthetized (isoflurane) to collect blood by cardiac puncture, and then euthanized (pentobarbital) to collect gastrocnemius muscle, liver, and epididymal adipose tissues. Excised tissues were flash-frozen in liquid nitrogen. Plasma glucose specific activity, glucose disposal rate (GDR), and hepatic glucose output (HGO) were calculated as previously described [39]. In a separate group of mice, acute insulin stimulation was achieved by intraperitoneal injection of 6 hr-fasted mice with 0.85 U/kg insulin. After 15 min, the mice were sacrificed and muscle was harvested as described above.
###end p 21
###begin title 22
Fluorescence-activated cell sorting (FACS) of adipose tissue SVCs
###end title 22
###begin p 23
###xml 103 106 103 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Nguyen1">[6]</xref>
Adipose tissue stromal vascular cells (SVCs) were isolated and analyzed by FACS as previously reported [6] with minor modifications. Briefly, freshly harvested epididymal fat pads were separately rinsed and minced in DPBS +1% BSA and then treated with 1 mg/mL type II collagenase (Sigma, St. Louis, MO) for 25 min in a 37degreesC shaking water bath. Adipose tissue cell suspensions were filtered through a 100 microm mesh. SVCs were separated from floating adipocytes by centrifugation, incubated in RBC lysis buffer (eBioscience, San Diego, CA) for 5 min, and re-suspended in fresh DPBS +1% BSA. SVCs were incubated with Fc Block (BD Biosciences, San Jose, CA) for 15 min and then stained for 30 min with fluorescent-conjugated antibodies against F4/80 (Ab Serotec, Raleigh, NC) and CD11b (BD Biosciences). Cells were washed two times and re-suspended in DPBS +1% BSA and propidium iodide (Sigma). Presence of the fluorescent stains in the SVCs was analyzed using a FACS Calibur flow cytometer (BD Biosciences). Control SVCs preparations included unstained cells, PI-only stained cells, and fluorescence-minus-one (FMO) stained cells and were used to set gatings and compensation.
###end p 23
###begin title 24
Plasma and tissue analyses
###end title 24
###begin p 25
###xml 70 75 <span type="species:ncbi:10090">Mouse</span>
Plasma insulin levels were measured using the Insulin Ultrasensitive (Mouse) EIA method (Alpco, Salem, NH). Muscle lysates were analyzed by western blotting with antibodies against total Akt and phospho-serine Akt (Cell Signaling, Danvers, MA). Signal intensities on chemiluminescence-exposed autoradiographs were densitometrically quantified using a digital Kodak 3D Image station and associated digital image analysis software (Kodak, New Haven, CT). The protein levels of IL-1beta, IL-12p70, IFNgamma, IL-6, IL-10, Cxcl1 and TNFalpha in adipose tissue lysates were measured using a multiplex (7-plex) ELISA (Meso Scale Discovery, Gaithersburg, MD).
###end p 25
###begin title 26
Statistical analyses
###end title 26
###begin p 27
Student's t-test and ANOVA (and Tukey's post hoc test) were applied for statistical analyses. A p-value cutoff of 0.05 was used to determine statistical significance.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
12/15LO expression increases chemokine production
###end title 29
###begin p 30
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Li1">[21]</xref>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Dwarakanath2">[22]</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Wen1">[24]</xref>
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Wen2">[26]</xref>
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Benz1">[37]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Kanda1">[40]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Kamei1">[41]</xref>
###xml 810 814 810 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Nomiyama1">[42]</xref>
###xml 940 948 940 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007250-g001">Figure 1</xref>
###xml 191 196 <span type="species:ncbi:9606">human</span>
Expression of 12/15LO in various smooth muscle cells and macrophages induces the expression of proinflammatory genes [21], [22], [24], [26]. We used fibroblast cell lines that stably express human 15LO or LacZ (as a negative control) [37] to test whether our 15LO-expressing cells (15LO cells) produce excess pro-inflammatory proteins compared to LacZ-expressing control cells (LacZ cells). We focused on chemokines that could attract monocytes to adipose tissue and have been shown to be involved in the pathogenesis of insulin resistance. Monocyte chemoattractant protein-1 (MCP-1) contributes to macrophage infiltration in adipose tissue and insulin resistance [40], [41]. Osteopontin (OPN) is a proinflammatory cytokine and monocyte chemotactic factor that also mediates obesity-induced insulin resistance [42]. We found that the 15LO cells expressed significantly higher levels of MCP-1 and OPN (mRNA and protein) than the LacZ cells (Figure 1). Expression of other inflammatory mediators TNFalpha, MIP-2, MIP-1alpha and IkappaBzeta was not different between the 15LO and LacZ cells (not shown).
###end p 30
###begin title 31
Proinflammatory chemokine production by 15LO-expressing cells.
###end title 31
###begin p 32
###xml 55 61 <span type="species:ncbi:10090">murine</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
A. Fold difference in OPN and MCP-1 mRNA expression in murine fibroblasts constitutively expressing human 15LO or LacZ. OPN and MCP-1 mRNA levels were measured by qPCR of total RNA and were normalized to GAPDH mRNA. B. Levels of MCP-1 protein in conditioned media from 15LO and LacZ cells, as assayed by ELISA. C. Autoradiograph of OPN protein in conditioned media from 15LO and LacZ cells, as determined by western blotting.
###end p 32
###begin title 33
###xml 67 71 <span type="species:ncbi:10090">mice</span>
HFD-induced inflammation in adipose tissue is absent in 12/15LO KO mice
###end title 33
###begin p 34
###xml 66 74 66 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007250-g001">Figure 1</xref>
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Li1">[21]</xref>
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Dwarakanath2">[22]</xref>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Wen1">[24]</xref>
###xml 642 645 642 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Strissel1">[5]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Kanda1">[40]</xref>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Weisberg1">[43]</xref>
###xml 932 940 932 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007250-g002">Figure 2</xref>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
###xml 1132 1136 <span type="species:ncbi:10090">mice</span>
###xml 1266 1270 <span type="species:ncbi:10090">mice</span>
Because 12/15LO regulates the expression of monocytic chemokines (Figure 1 and refs. [21], [22], [24]), we compared the effects of short-term high fat feeding on adipose tissue inflammation in C57BL6 wild type (WT) and strain-, gender-, and age-matched 12/15LO knockout (KO) mice. We assessed adipose tissue macrophage infiltration in isolated epididymal white adipose tissue-derived stromal vascular cells (SVCs) using fluorescence-activated cell sorting (FACS), which is a more sensitive and comprehensive method compared to immuno-histochemistry. Because macrophages expressing F4/80 and/or CD11b are increased in adipose tissue after HFD [5], [40], [43], we measured the percentage of live SVCs that express F4/80 or CD11b and the percentage of live SVCs that express both F4/80 and CD11b. The percentage of adipose tissue-derived SVCs expressing F4/80 and/or CD11b was significantly increased in WT mice fed HFD for two weeks (Figure 2) compared to WT mice fed normal chow (NC). This trend of increased macrophage presence also existed after four weeks of HFD. In contrast, adipose tissue-derived SVCs isolated from 12/15LO KO mice fed HFD for four weeks exhibited no change in the percentage of cells expressing F4/80 and CD11b compared with NC-fed 12/15LO KO mice.
###end p 34
###begin title 35
FACS analysis of macrophage content in adipose tissue SVCs.
###end title 35
###begin p 36
###xml 260 261 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">$</sup>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
A. HFD-induced fold change in the percent of live adipose tissue SVCs expressing surface markers F4/80, CD11b, and both F4/80 and CD11b. SVCs were isolated from eWAT of mice fed NC, two-week HFD, or four-week HFD. *p<0.05 vs WT NC, Ë†p<0.05 vs WT two-week HFD, $p<0.05 vs WT four-week HFD.
###end p 36
###begin p 37
###xml 304 312 297 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007250-g003">Figure 3</xref>
###xml 814 822 792 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007250-g003">Figure 3</xref>
###xml 929 937 907 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007250-g002">Figure 2</xref>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">mice</span>
###xml 987 991 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
We next measured cytokine protein levels in epididymal white adipose tissue (eWAT) lysates from WT and 12/15LO KO mice fed NC or HFD for two weeks. We observed significantly elevated levels of IL-1beta, IL-12p70, IFNgamma, IL-6, and IL-10 in eWAT lysates from HFD-fed WT mice compared to NC-fed WT mice (Figure 3). Cxcl1 (KC) and TNFalpha levels also tended to increase after HFD in WT mice but this increase did not reach statistical significance. None of these cytokines were elevated in the plasma of WT mice fed 2-week HFD compared to NC controls. In contrast to WT mice, 12/15LO KO mice were completely protected from HFD-induced increases in IL-1beta, IL-12p70, IFNgamma, IL-6, IL-10, Cxcl1 and TNFalpha levels in eWAT. The absence of HFD-induced cytokine elevation in the adipose tissue of 12/15LO KO mice (Figure 3) corresponds with the absence of HFD-induced macrophage infiltration in the adipose tissue of these mice (Figure 2) and supports the notion that, in contrast to WT mice, 12/15LO KO mice fed HFD for two to four weeks do not exhibit macrophage-mediated, adipose tissue inflammation.
###end p 37
###begin title 38
Adipose tissue cytokine levels.
###end title 38
###begin p 39
###xml 212 213 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Cytokine protein levels measured in eWAT lysates from WT (black bars) and 12/15LO KO (gray bars) mice fed NC or two-week HFD. Values are mean+/-standard error. 8-10 animals per group. *p<0.05 vs diet-matched WT, #p<0.05 vs strain-matched NC.
###end p 39
###begin title 40
###xml 11 15 <span type="species:ncbi:10090">mice</span>
12/15LO KO mice are protected from HFD-induced insulin resistance
###end title 40
###begin p 41
###xml 518 529 518 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007250-g004">Figure 4A&#8211;C</xref>
###xml 1176 1183 1170 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007250-t001">Table 1</xref>
###xml 1377 1386 1371 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007250-g004">Figure 4D</xref>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 1067 1071 <span type="species:ncbi:10090">mice</span>
###xml 1170 1174 <span type="species:ncbi:10090">mice</span>
###xml 1299 1303 <span type="species:ncbi:10090">mice</span>
###xml 1515 1519 <span type="species:ncbi:10090">mice</span>
We investigated whether the absence of HFD-induced adipose tissue inflammation in 12/15LO KO mice correlated with protection from whole body insulin resistance. We conducted euglycemic hyperinsulinemic clamp studies on WT and 12/15LO KO mice fed NC or HFD for two weeks. High fat feeding induced significant differences in clamp data from HFD-fed compared to NC-fed WT mice, specifically, 76% lower glucose infusion rate (Ginf), 60% lower glucose disposal rate (GDR), and 76% higher hepatic glucose output rate (HGO) (Figure 4A-C). 12/15LO KO mice were completely protected from the severe HFD-induced changes in Ginf, GDR, and HGO that we observed in WT mice. There was no significant difference in basal glucose turnover rate (basal HGO = basal GDR) between the NC-fed WT (15.9+/-2.2 mg/kg/min) and 12/15LO KO mice (16.0+/-1.9 mg/kg/min) or between the WT NC-fed and WT HFD-fed mice (15.7+/-1.9 mg/kg/min). The clamp study data indicate that 12/15LO deficiency provides protection from HFD-induced hepatic and skeletal muscle insulin resistance. HFD-fed 12/15LO KO mice did exhibit a similar fold increase in eWAT mass but not hyperinsulinemia, compared to HFD-fed WT mice (Table 1). To demonstrate that there was no direct dependency between adiposity and insulin resistance in WT and 12/15LO KO mice, we normalized the GDR values to the fat pad mass as a % of body weight. Figure 4D shows that, even after this normalization, there remains a dramatically different insulin sensitivity between WT and 12/15LO KO mice fed chow or high-fat diet.
###end p 41
###begin title 42
Characterization of whole body insulin sensitivity.
###end title 42
###begin p 43
###xml 316 317 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
Hyperinsulinemic euglycemic clamp studies were conducted to calculate (A) Ginf, (B) GDR, (C) HGO, and (D) GDR normalized to fat pad mass as a percent of body weight in WT (black bars) and 12/15LO KO (gray bars) mice fed NC or two-week HFD. Values are mean+/-standard error. 7-9 animals per group. *p<0.05 vs WT HFD, #p<0.05 vs WT NC.
###end p 43
###begin title 44
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse strain characteristics.
###end title 44
###begin p 45
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Data are averages+/-standard error. 7-10 mice per group. * p<0.05 vs diet-matched WT, # p<0.05 vs strain-matched NC. ns - not significant.
###end p 45
###begin title 46
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Diminished insulin-activated Akt phosphorylation in muscle from HFD-fed WT compared to 12/15LO KO mice
###end title 46
###begin p 47
###xml 259 262 259 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 393 396 393 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 486 494 486 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007250-g005">Figure 5</xref>
###xml 869 876 869 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 886 895 886 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007250-g004">Figure 4B</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 995 999 <span type="species:ncbi:10090">mice</span>
In order to assess the effects of 12/15LO KO on insulin signal transduction in skeletal muscle from mice fed HFD, we examined acute insulin-activated Akt phosphorylation in a separate group of mice. Serine-phosphorylation of Akt in muscle lysates (phospho-Ser473 Akt normalized to total Akt protein) was determined by western blot using primary antibodies for total Akt protein and phospho-Ser473 Akt. As expected, acute insulin treatment induced phosphorylation of Akt in both groups (Figure 5). However, the absolute level of insulin-stimulated Akt phosphorylation and the insulin-stimulated fold change in Akt phosphorylation were both significantly greater, two- and three-fold, respectively, in 12/15LO KO mice compared to WT mice. Because activation (phosphorylation) of Akt is a critical early event in the insulin receptor signaling, these data corroborate our in vivo results (Figure 4B) demonstrating greater insulin sensitivity in the muscle of HFD-fed 12/15LO KO mice compared to WT mice.
###end p 47
###begin title 48
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Basal and insulin-stimulated Akt phosphorylation in muscle of HFD-fed mice.
###end title 48
###begin p 49
###xml 248 251 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 428 431 428 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">Mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
WT (black bars) and 12/15LO KO (gray bars) mice were fed HFD for two weeks. Mice were then injected intraperitoneally with 0.85 U/kg insulin or vehicle. After 15 min, mice were sacrificed and gastrocnemius muscles were rapidly isolated. Phospho-Ser473 Akt and total Akt levels in muscle lysates were measured by western blotting. A. Representative western blot images. B. Quantitation of all Akt western blot images. Phospho-Ser473 Akt/total Akt ratio values were normalized to the maximal signal observed. Bar graph values are mean+/-standard error. Insulin-induced fold changes in Akt phosphorylation are shown within the bars. 2-6 animals per group. *p<0.05.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Strissel1">[5]</xref>
###xml 364 367 364 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Nguyen1">[6]</xref>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
###xml 1299 1303 <span type="species:ncbi:10090">mice</span>
###xml 1412 1416 <span type="species:ncbi:10090">mice</span>
HFD-induced and obesity-related insulin resistance is associated with chronic low grade inflammation in adipose tissue characterized by macrophage infiltration and elevation of inflammatory cytokine expression. HFD-induced effects on adipose tissue inflammation are initiated early in the course of high fat feeding and are coincident with insulin resistance [5], [6]. Although the known biological roles of 12/15LO include regulating inflammation, a role for 12/15LO in the early development of HFD-induced adipose tissue inflammation and/or whole body insulin resistance has not been described. 12/15LO is expressed in all vascular cell types, including endothelial cells, macrophages and VSMCs, and its expression is elevated under inflammatory conditions. Therefore, we hypothesized that 12/15LO might regulate HFD-induced adipose tissue inflammation. Indeed, we found that high fat feeding induced macrophage infiltration into adipose tissue of WT but not 12/15LO KO mice, presumably, via 12/15LO-regulated chemokine secretion. The difference in adipose tissue macrophage infiltration between HFD-fed WT and 12/15LO KO mice corresponded with their difference in adipose tissue inflammatory cytokine elevation. In addition to being protected from adipose tissue inflammation, HFD-fed 12/15LO KO mice were also dramatically protected from hepatic and skeletal muscle insulin resistance compared to HFD-fed WT mice.
###end p 51
###begin p 52
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Bolick1">[12]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Bolick2">[36]</xref>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Patricia1">[44]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Hatley1">[45]</xref>
###xml 653 657 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Bolick1">[12]</xref>
###xml 659 663 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Bolick2">[36]</xref>
###xml 755 759 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Li1">[21]</xref>
###xml 761 765 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Wen1">[24]</xref>
###xml 767 771 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Wen2">[26]</xref>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
Adipose tissue macrophages are derived from circulating monocytes that attach to and migrate through endothelial cells (ECs) in the tissue microvasculature. 12/15LO expression and activity is increased in atherogenic and hyperglycemic diabetes models [12], [36], [44], [45], conditions similar to the postprandial state of non-diabetic, diet-induced insulin resistance in which case hyperlipidemia and hyperglycemia are more pronounced and sustained. In these model conditions, activated 12/15LO regulates monocyte attachment to ECs in part by increasing expression of adhesion molecule ICAM-1 on the surface of ECs via activation of RhoA and NF-kappaB [12], [36]. 12/15LO increases the expression of chemokines MCP-1 and OPN (our data presented here and [21], [24], [26]). Thus, 12/15LO-mediated regulation of chemoattractants and an adhesion receptor may account for the increased monocyte infiltration into adipose tissue that we observed in HFD-fed WT but not 12/15LO KO mice.
###end p 52
###begin p 53
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Nunemaker1">[30]</xref>
###xml 1038 1042 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Chakrabarti1">[46]</xref>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 1339 1343 <span type="species:ncbi:10090">mice</span>
Both WT and 12/15LO KO mice exhibited an approximate two-fold increase in eWAT mass during the two-week high fat feeding period. Although HFD-induced eWAT expansion in 12/15LO KO mice was somewhat blunted compared to WT mice, the fold change in mass compared to NC-fed controls was statistically indistinguishable from that in WT mice. Despite similar eWAT expansion, the number of macrophages and levels of pro-inflammatory cytokines in eWAT from 12/15LO KO mice were completely unchanged by HFD, and significantly different from the elevated levels we observed in HFD-fed WT mice. Our findings suggest that the proinflammatory effects of 12/15LO expression observed by Nunemaker, et al. after 8 and 24 weeks of HFD [30] in fact occur significantly earlier during the initial stages of HFD-induced insulin resistance (2-4 weeks). Chakrabarti, et al. have recently demonstrated that 12/15LO is up-regulated in adipose tissue from high fat fed mice and that 12/15LO products induce inflammation and insulin resistance in 3T3-L1 adipoctyes [46]. HFD-induced elevation of eWAT cytokine levels could originate from macrophages, adipocytes, endothelial cells and/or preadipocytes within adipose tissue. We speculate that pro-inflammatory macrophages and adipocytes are the most likely sources of elevated eWAT cytokines in high fat diet-fed WT mice.
###end p 53
###begin p 54
###xml 278 281 278 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Park1">[4]</xref>
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Kraegen1">[8]</xref>
###xml 471 474 471 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Park1">[4]</xref>
###xml 475 478 475 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Nguyen1">[6]</xref>
###xml 912 915 912 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-deLuca1">[1]</xref>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007250-Trayhurn1">[47]</xref>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 287 292 <span type="species:ncbi:10090">Mouse</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
We used a two- and four-week high fat feeding protocol because it significantly induces the phenotypes of insulin resistance and adipose tissue hypertrophy and inflammation in WT mice without causing the severe metabolic dysfunctions that manifest after longer high fat feeding [4]-[8]. Mouse phenotypes induced by our high fat feeding protocol were similar to those observed in other time course studies of HFD-induced adipose tissue inflammation and insulin resistance [4]-[6]. Two-week high fat feeding induced hyperinsulinemia and severe hepatic and skeletal muscle insulin resistance in WT but not 12/15LO KO mice. 12/15LO KO mice exhibited significantly greater insulin-stimulated skeletal muscle Akt phosphorylation after HFD, compared to WT mice, corresponding to their greater insulin sensitivity. Given the cross-talk between adipose tissue, liver, and skeletal muscle that affects insulin sensitivity [1], [47], protection from adipose tissue inflammation in the 12/15LO KO mice may be the primary site of action leading to protection from whole body insulin resistance.
###end p 54
###begin p 55
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 420 431 <span type="species:ncbi:9606">participant</span>
###xml 546 551 <span type="species:ncbi:9606">human</span>
In summary, we find that 12/15LO is a key modulator of the onset of high fat diet-induced insulin resistance in liver, muscle and adipose tissue. We provide evidence that the mechanism by which the 12/15LO KO mice are protected from the initial stages of HFD-induced insulin resistance involves suppression of adipose tissue pro-inflammatory macrophage infiltration and inflammatory cytokine elevation. 12/15LO is a key participant in the development of diet-induced insulin resistance and, thus, a viable therapeutic target for the treatment of human insulin resistance and type 2 diabetes.
###end p 55
###begin p 56
We thank D.J. Young and the Flow Cytometry Resource at the Rebecca & John Moores UCSD
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
Inflammation and insulin resistance.
###end article-title 58
###begin article-title 59
The metabolic syndrome and adipocytokines.
###end article-title 59
###begin article-title 60
Inflammation and metabolic disorders.
###end article-title 60
###begin article-title 61
###xml 123 127 <span type="species:ncbi:10090">mice</span>
Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice.
###end article-title 61
###begin article-title 62
Adipocyte death, adipose tissue remodeling, and obesity complications.
###end article-title 62
###begin article-title 63
A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways.
###end article-title 63
###begin article-title 64
Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle.
###end article-title 64
###begin article-title 65
###xml 88 92 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats.
###end article-title 65
###begin article-title 66
Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells.
###end article-title 66
###begin article-title 67
Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions.
###end article-title 67
###begin article-title 68
Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway.
###end article-title 68
###begin article-title 69
12/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kappaB.
###end article-title 69
###begin article-title 70
IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase and up-regulation of 15-lipoxygenase 1 expression.
###end article-title 70
###begin article-title 71
Lipoxygenase metabolism: roles in tumor progression and survival.
###end article-title 71
###begin article-title 72
Jasmonate: an oxylipin signal with many roles in plants.
###end article-title 72
###begin article-title 73
###xml 26 46 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
Jasmonate biosynthesis in Arabidopsis thaliana-enzymes, products, regulation.
###end article-title 73
###begin article-title 74
Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells.
###end article-title 74
###begin article-title 75
Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells.
###end article-title 75
###begin article-title 76
Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.
###end article-title 76
###begin article-title 77
Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B).
###end article-title 77
###begin article-title 78
Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs.
###end article-title 78
###begin article-title 79
Viral vector-mediated 12/15-lipoxygenase overexpression in vascular smooth muscle cells enhances inflammatory gene expression and migration.
###end article-title 79
###begin article-title 80
12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo.
###end article-title 80
###begin article-title 81
The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages.
###end article-title 81
###begin article-title 82
Lipid inflammatory mediators in diabetic vascular disease.
###end article-title 82
###begin article-title 83
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages.
###end article-title 83
###begin article-title 84
###xml 75 80 <span type="species:ncbi:9606">human</span>
The role of arachidonic acid and its metabolites in insulin secretion from human islets of langerhans.
###end article-title 84
###begin article-title 85
Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity.
###end article-title 85
###begin article-title 86
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.
###end article-title 86
###begin article-title 87
###xml 25 29 <span type="species:ncbi:10090">mice</span>
12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet.
###end article-title 87
###begin article-title 88
Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells.
###end article-title 88
###begin article-title 89
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice.
###end article-title 89
###begin article-title 90
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.
###end article-title 90
###begin article-title 91
Lipoxygenase pathways in atherogenesis.
###end article-title 91
###begin article-title 92
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.
###end article-title 92
###begin article-title 93
###xml 98 102 <span type="species:ncbi:10090">mice</span>
12/15 lipoxygenase mediates monocyte adhesion to aortic endothelium in apolipoprotein E-deficient mice through activation of RhoA and NF-kappaB.
###end article-title 93
###begin article-title 94
###xml 75 81 <span type="species:ncbi:10090">murine</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase.
###end article-title 94
###begin article-title 95
Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase.
###end article-title 95
###begin article-title 96
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency.
###end article-title 96
###begin article-title 97
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.
###end article-title 97
###begin article-title 98
Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance.
###end article-title 98
###begin article-title 99
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.
###end article-title 99
###begin article-title 100
Obesity is associated with macrophage accumulation in adipose tissue.
###end article-title 100
###begin article-title 101
Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells.
###end article-title 101
###begin article-title 102
###xml 119 123 <span type="species:ncbi:10090">mice</span>
Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice.
###end article-title 102
###begin article-title 103
12/15-Lipoxygenase Products Induce Inflammation and Impair Insulin Signaling in 3T3-L1 Adipocytes.
###end article-title 103
###begin article-title 104
Signalling role of adipose tissue: adipokines and inflammation in obesity.
###end article-title 104
###begin p 105
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
###xml 515 521 <span type="species:ncbi:9606">person</span>
Competing Interests: Support for this research was provided, in part, by the University of California Discovery Program Project #bio03-10383 with matching grant funds provided by Pfizer, Inc (DDS, JMO). JC is an employee of Pfizer and participated as a collaborator in sample and data analysis for the project. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. JC participated as described above, no other person or entity of Pfizer, Inc. had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no other competing interests (as listed in the PLoS Competing Interests Policy) known to us.
###end p 105
###begin p 106
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 591 597 <span type="species:ncbi:9606">person</span>
Funding: Support for this research was provided by NIH grants K01-DK62025 (DDS) and R01HL081862 (DDS, PDM, YIM), American Heart Association grant 0530159N (YIM), and the University of California Discovery Program Project #bio03-10383 with matching grant funds provided by Pfizer, Inc. (JMO, DDS). JC is an employee of Pfizer and participated in sample and data analysis for the project. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. JC participated as described above, no other person or entity of Pfizer, Inc. had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 106

